Scotride MP 1mg/500mg/15mg Tablet SR
Marketer
Adenscot Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Scotride MP 1mg/500mg/15mg Tablet SR
Diabex-Trio (1mg/500mg/15mg) extended-release tablets are a combined medication for managing blood glucose. In adults with type 2 diabetes, this medication, used alongside diet and exercise, improves glycemic control by enhancing insulin effectiveness and thus reducing blood sugar. Always adhere to your physician's prescribed dosage and duration. Take with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, skip the missed dose and resume your usual schedule. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals may increase the risk of hypoglycemia. Regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your doctor of any kidney, liver, or heart conditions before starting this medication. Pregnant or breastfeeding individuals should consult their doctor. Kidney function tests will be assessed before treatment initiation. Limit alcohol consumption as it may heighten the risk of side effects.
Uses of Scotride MP 1mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Scotride MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Scotride MP 1mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Scotride MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Scotride MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Scotride MP 1mg/500mg/15mg Extended-Release Tablet should be administered with a meal.
How Scotride MP 1mg/500mg/15mg Tablet SR works:
Scotride MP tablets (1mg/500mg/15mg sustained-release) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach improves blood sugar management when single or dual medication proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts via reduced hepatic glucose production, slowed intestinal glucose absorption, and enhanced insulin responsiveness. Pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Scotride MP 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Scotride MP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Scotride MP tablets (1mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is a potential consequence of both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Scotride MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. The medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Scotride MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Scotride MP 1mg/500mg/15mg SR tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Scotride MP 1mg/500mg/15mg Tablet SR :
Should you forget to take a Scotride MP 1mg/500mg/15mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Scotride MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Diabetes medication |
3,018 People bought this recently